JP Morgan closes Kangji Medical derivative contracts
JP Morgan Securities PLC closed several derivative contracts linked to Kangji Medical Holdings Limited on August 18, 2025, as part of the company's ongoing privatisation.
The transactions involved closing contracts totaling over $1.3m, including a large position of 123,000 units at $8.6936 worth $1.07m and another 25,500 units at $8.6834 for $221,427.
Following the closings, JP Morgan Securities held 8,997,503 shares. The firm is a Class 5 associate connected with the privatisation offeror and is ultimately owned by JPMorgan Chase & Co.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Kangji Medical Holdings publishes news
Free account required • Unsubscribe anytime